annual EBIT:
-$266.90M-$31.02M(-13.15%)Summary
- As of today (September 19, 2025), VRDN annual earnings before interest & taxes is -$266.90 million, with the most recent change of -$31.02 million (-13.15%) on December 31, 2024.
- During the last 3 years, VRDN annual EBIT has fallen by -$187.49 million (-236.11%).
- VRDN annual EBIT is now -135383.76% below its all-time high of -$197.00 thousand, reached on December 31, 2013.
Performance
VRDN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$106.77M-$12.90M(-13.74%)Summary
- As of today (September 19, 2025), VRDN quarterly earnings before interest & taxes is -$106.77 million, with the most recent change of -$12.90 million (-13.74%) on June 30, 2025.
- Over the past year, VRDN quarterly EBIT has dropped by -$34.58 million (-47.90%).
- VRDN quarterly EBIT is now -2093570.59% below its all-time high of $5100.00, reached on December 31, 2013.
Performance
VRDN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$371.58M-$34.58M(-10.26%)Summary
- As of today (September 19, 2025), VRDN TTM earnings before interest & taxes is -$371.58 million, with the most recent change of -$34.58 million (-10.26%) on June 30, 2025.
- Over the past year, VRDN TTM EBIT has dropped by -$120.80 million (-48.17%).
- VRDN TTM EBIT is now -268580.40% below its all-time high of -$138.30 thousand, reached on December 31, 2013.
Performance
VRDN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
VRDN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.2% | -47.9% | -48.2% |
| 3 y3 years | -236.1% | -261.1% | -276.6% |
| 5 y5 years | -550.4% | -1601.7% | -944.6% |
VRDN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -236.1% | at low | -261.1% | at low | -276.6% | at low |
| 5 y | 5-year | -550.4% | at low | -1910.7% | at low | -1153.1% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | at low |
VRDN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$106.77M(+13.7%) | -$371.58M(+10.3%) |
| Mar 2025 | - | -$93.87M(+7.3%) | -$337.00M(+12.7%) |
| Dec 2024 | -$266.90M(+13.1%) | -$87.47M(+4.8%) | -$299.04M(+5.7%) |
| Sep 2024 | - | -$83.48M(+15.6%) | -$283.04M(+12.9%) |
| Jun 2024 | - | -$72.19M(+29.1%) | -$250.79M(+5.4%) |
| Mar 2024 | - | -$55.90M(-21.8%) | -$237.88M(-6.5%) |
| Dec 2023 | -$235.89M(+82.3%) | -$71.48M(+39.5%) | -$254.45M(+9.7%) |
| Sep 2023 | - | -$51.22M(-13.6%) | -$232.04M(+10.2%) |
| Jun 2023 | - | -$59.27M(-18.2%) | -$210.60M(+16.4%) |
| Mar 2023 | - | -$72.47M(+47.7%) | -$180.89M(+34.7%) |
| Dec 2022 | -$129.39M(+62.9%) | -$49.07M(+64.7%) | -$134.30M(+17.5%) |
| Sep 2022 | - | -$29.79M(+0.7%) | -$114.32M(+15.9%) |
| Jun 2022 | - | -$29.56M(+14.2%) | -$98.67M(+13.3%) |
| Mar 2022 | - | -$25.89M(-11.0%) | -$87.10M(+9.2%) |
| Dec 2021 | -$79.41M(-27.9%) | -$29.08M(+105.8%) | -$79.73M(+11.7%) |
| Sep 2021 | - | -$14.13M(-21.5%) | -$71.38M(+14.1%) |
| Jun 2021 | - | -$18.00M(-2.8%) | -$62.55M(+23.1%) |
| Mar 2021 | - | -$18.52M(-10.7%) | -$50.83M(+26.1%) |
| Dec 2020 | -$110.21M(+168.5%) | -$20.73M(+290.4%) | -$40.31M(+35.9%) |
| Sep 2020 | - | -$5.31M(-15.4%) | -$29.65M(-16.6%) |
| Jun 2020 | - | -$6.27M(-21.6%) | -$35.57M(-7.0%) |
| Mar 2020 | - | -$8.00M(-20.6%) | -$38.24M(-8.9%) |
| Dec 2019 | -$41.04M | -$10.07M(-10.3%) | -$41.98M(-0.9%) |
| Sep 2019 | - | -$11.23M(+25.6%) | -$42.36M(+5.2%) |
| Jun 2019 | - | -$8.94M(-23.8%) | -$40.28M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.74M(+12.3%) | -$40.20M(+21.5%) |
| Dec 2018 | -$31.83M(+21.8%) | -$10.45M(+14.2%) | -$33.08M(+14.1%) |
| Sep 2018 | - | -$9.15M(+3.3%) | -$28.98M(+12.7%) |
| Jun 2018 | - | -$8.86M(+91.8%) | -$25.72M(+6.2%) |
| Mar 2018 | - | -$4.62M(-27.3%) | -$24.21M(-8.7%) |
| Dec 2017 | -$26.13M(+107.7%) | -$6.35M(+7.9%) | -$26.53M(+1.7%) |
| Sep 2017 | - | -$5.89M(-19.9%) | -$26.09M(+7.4%) |
| Jun 2017 | - | -$7.35M(+5.9%) | -$24.29M(+25.1%) |
| Mar 2017 | - | -$6.94M(+17.3%) | -$19.42M(+27.6%) |
| Dec 2016 | -$12.58M(+12.4%) | -$5.91M(+44.9%) | -$15.21M(+24.1%) |
| Sep 2016 | - | -$4.08M(+64.3%) | -$12.26M(+8.4%) |
| Jun 2016 | - | -$2.48M(-9.2%) | -$11.30M(-0.1%) |
| Mar 2016 | - | -$2.73M(-7.5%) | -$11.31M(+1.1%) |
| Dec 2015 | -$11.19M(+62.9%) | -$2.96M(-5.5%) | -$11.19M(+5.7%) |
| Sep 2015 | - | -$3.13M(+25.6%) | -$10.59M(+16.4%) |
| Jun 2015 | - | -$2.49M(-4.7%) | -$9.09M(-3.4%) |
| Mar 2015 | - | -$2.61M(+10.9%) | -$9.41M(+38.4%) |
| Dec 2014 | -$6.87M(+3385.8%) | -$2.36M(+44.3%) | -$6.80M(+53.2%) |
| Sep 2014 | - | -$1.63M(-41.9%) | -$4.44M(+50.5%) |
| Jun 2014 | - | -$2.81M(<-9900.0%) | -$2.95M(+2032.8%) |
| Dec 2013 | -$197.00K(-95.1%) | $5100.00(-103.6%) | -$138.30K(-64.7%) |
| Sep 2013 | - | -$143.40K(-42.3%) | -$391.90K(-53.0%) |
| Dec 2012 | -$4.03M | - | - |
| Dec 2012 | - | -$248.50K(-57.5%) | -$833.50K(+42.5%) |
| Sep 2012 | - | -$585.00K | -$585.00K |
FAQ
- What is Viridian Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual EBIT year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Viridian Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM EBIT year-on-year change?
What is Viridian Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of VRDN is -$266.90M
What is the all time high annual EBIT for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$197.00K
What is Viridian Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, VRDN annual earnings before interest & taxes has changed by -$31.02M (-13.15%)
What is Viridian Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of VRDN is -$106.77M
What is the all time high quarterly EBIT for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $5100.00
What is Viridian Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, VRDN quarterly earnings before interest & taxes has changed by -$34.58M (-47.90%)
What is Viridian Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of VRDN is -$371.58M
What is the all time high TTM EBIT for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$138.30K
What is Viridian Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, VRDN TTM earnings before interest & taxes has changed by -$120.80M (-48.17%)